Yuyu Pharma announced on March 24 its plan to enhance corporate value by increasing shareholder returns and shareholder value through the cancellation of treasury shares and an increase in dividends.


Exterior view of the headquarters of Yuyu Pharma located in Jecheon City, Chungbuk. Yuyu Pharma

Exterior view of the headquarters of Yuyu Pharma located in Jecheon City, Chungbuk. Yuyu Pharma

View original image

Yuyu Pharma will complete the cancellation of its treasury shares held during the first half of the year, thereby implementing an active shareholder return policy. In addition, the company plans to increase dividends with the goal of maintaining high dividend payouts that are subject to separate taxation. Last year, Yuyu Pharma’s profit dividends amounted to 2.1 billion won, up 10.7% from the previous year, with a dividend payout ratio of 26.2%.


Noyong Park, CEO of Yuyu Pharma, stated, "We decided to cancel treasury shares and increase cash dividends in order to reward the support of shareholders who have trusted and supported the company," adding, "We will continue to pursue management activities that promote coexistence between the company and its shareholders."



In the previous year, Yuyu Pharma recorded consolidated sales of 140.8 billion won, operating profit of 11 billion won, and net profit of 9.1 billion won, achieving solid management results for two consecutive years.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.

Today’s Briefing